Cases & Deals

  • Home
  • Practices
  • Mauna Kea completes IPO and raises €56.5 million on NYSE Euronext in Paris

Share

Mauna Kea completes IPO and raises €56.5 million on NYSE Euronext in Paris

July 2011

Client(s) Mauna Kea Technologies

Jones Day advised Mauna Kea Technologies, a global medical device company focused on leading innovation in endomicroscopy, in connection with its IPO on the regulated market of NYSE Euronext in Paris, underwritten by Société Générale, Dexia Securities France, and Gilbert Dupont, in which the company raised €56.5 million (US$81.8 million).

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.